Yanlei Zhang

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 3

Top Topics

Acute Lymphoblastic Leukemia

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Cancer immunology research

This page only lists publications with an associated author ORCID identifier.

Publications

Jieyun Xia, Hujun Li, Zhiling Yan, Dian Zhou, Ying Wang, Yuekun Qi, Jiang Cao, Depeng Li, Hai Cheng, Wei Sang, Feng Zhu, Haiying Sun, Wei Chen, Kunming Qi, Dongmei Yan, Tingting Qiu, Jianlin Qiao, Ruosi Yao, Yang Liu, Xue Wang, Yanlei Zhang, Shuixiu Peng, Chih-Hua Huang, Junnian Zheng, Zhenyu Li, Alex H Chang, Kailin Xu
Anti-G Protein-Coupled Receptor, Class C Group 5 Member D Chimeric Antigen Receptor T Cells in Patients With Relapsed or Refractory Multiple Myeloma: A Single-Arm, Phase Ⅱ Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Jing Pan, Yue Tan, Guoling Wang, Biping Deng, Zhuojun Ling, Weiliang Song, Samuel Seery, Yanlei Zhang, Shuixiu Peng, Jinlong Xu, Jiajia Duan, Zelin Wang, Xinjian Yu, Qinlong Zheng, Xiuwen Xu, Ying Yuan, Fangrong Yan, Zhenglong Tian, Kaiting Tang, Jiecheng Zhang, Alex H Chang, Xiaoming Feng
Donor-Derived CD7 Chimeric Antigen Receptor T Cells for T-Cell Acute Lymphoblastic Leukemia: First-in-Human, Phase I Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (30) (2021)
Guoqing Wei, Yanlei Zhang, Houli Zhao, Yiyun Wang, Yandan Liu, Bin Liang, Xiujian Wang, Huijun Xu, Jiazhen Cui, Wenjun Wu, Kui Zhao, Arnon Nagler, Alex H Chang, Yongxian Hu, He Huang
CD19/CD22 Dual-Targeted CAR T-cell Therapy for Relapsed/Refractory Aggressive B-cell Lymphoma: A Safety and Efficacy Study. Cancer immunology research 9 (9) (2021)